In the UK, up to a tenth of the 3,000 research and development workers, who focus on gastrointestinal and heart issues, at AstraZeneca's Alderley Park site in Cheshire will be made redundant.
The nation's second-largest pharmaceutical firm has 61,000 employees worldwide, with 8,000 in the UK. It cut 12,600 positions between 2007 and 2009, with a further 9,000 roles axed by the end of last year. For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today
No comments:
Post a Comment